Cuba presents results of its COVID-19 vaccines to WHO experts
During the meeting, the first to be held with representatives of the WHO and PAHO to address the approval of ...
During the meeting, the first to be held with representatives of the WHO and PAHO to address the approval of ...
According to CNN, Cuba did not receive an emergency use license for its COVID-19 vaccine from the WHO. BioCubaFarma affirms ...
The director of Science and Innovation of the Cuban Ministry of Public Health, Ileana Morales, explained that in September “all ...
In an article on its website, the Vietnamese government pointed out that the offer stems from a telephone conversation the ...
The province was also the venue of the phase I, II and III clinical trials of Soberana 02, which made ...
According to the MINSAP, to date 3,491,529 people have received at least one dose of one of the Cuban vaccine ...
According to a statement from the Center for Genetic Engineering and Biotechnology (CIGB), it is a study without placebo, which ...
Of the 48,000 volunteers involved in the phase III clinical trial, only 153 were infected with the virus and among ...
The announcement was made by the island’s prime minister, Manuel Marrero, during a television appearance, in which he also ratified ...
“The efficacy of 2 doses of the Soberana 02 vaccine and the booster dose, Soberana Plus, in the third phase ...
CECMED made the approval effective through Resolution No. 113 dated July 9, 2021, after “concluding a rigorous evaluation process of ...
This figure is higher than that established by the World Health Organization (WHO) to consider SARS-CoV-2 immunogens as effective vaccines.
The trial — called “Ismaelillo” — will include 592 volunteer children and teenagers aged between 3 and 18 years living ...
He was reported in serious condition in the Florida municipality of Camagüey, where he had a five-day hospital stay.
The volunteer selection process was carried out after verifying the safety of the drug in volunteers aged 12 to 18 ...
The preliminary results of the third and final stage of testing of the Soberana 02 and Abdala vaccine candidates were ...
The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).
The director of the Finlay Vaccine Institute, Vicente Vérez, specified on state television that the percentage has been obtained from ...
Although the data on the efficacy of the most advanced candidates are not yet known, Cuban scientists assure that the ...
Dr. Vicente Vérez, director of the Finlay Vaccine Institute (IFV), confirmed this Wednesday that his center is only waiting for ...
The island’s health institutions have administered 1,843,490 doses of both COVID-19 drugs, still awaiting the results of the third phase ...
The principal investigator of the clinical trials, Arturo Chang, pointed out that as part of the studies, the levels of ...
The new centers for the application of the vaccine candidate are distributed in three of the capital’s municipalities where the ...
“The idea is that any Cuban can have that digital passport printed, in the application on a mobile phone, send ...
However, Cuban specialists aspire to higher figures, as confirmed by the Director of Clinical Research at the Center for Genetic ...
OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.